Medical Devices Research Reports Medical Cyclotrons Market | Page 2

confirming presence of cancerous cells at the affected site. Radioactive isotopes have
short half-life (e.g. Flourine-18 has a half-life of about 110 minutes) that results in
immediate decay after their production. Therefore many research and large diagnostic
facilities possess assembled in-house medical cyclotron to produce radioactive isotopes
for various medical applications.
Medical Cyclotron Market - Market Dynamics
High prevalence of cancer is expected to be a major factor driving growth of the medical
cyclotron market. This is due to the ability of medical cyclotron to detect cancer, observe
response of cancer treatments, and check recurrence of the disease using PET scan
techniques. For instance, according to World Health Organization (WHO) factsheet in
February, cancer is one of leading non-communicable disease and second leading cause
of death, worldwide. Moreover, according to a report by International Age for Research
on Cancer (IARC) in 2012, around 14.1 million new cases of cancer, along with around
8.8 million death were registered for 2012. The report further stated that around 32.6
million people were suffering from cancer. Moreover, PET scan is widely utilized in
treatment of cardiovascular diseases and central nervous system-associated diseases
such as Alzheimer’s and Parkinson’s disease. High prevalence of these diseases is a
major factor contributing to increasing demand for diagnostics treatments with PET scans,
which in turn is expected to propel growth of the medical cyclotron market. Furthermore,
PET scan can benefits precision medicine and nuclear medicine for chronic disease
(finding new radioisotopes and treatment targets) worldwide which would aid medical
cyclotron market. Academic research campuses are increasingly adopting to in-house
medical cyclotron to boost research in nuclear medicine and radiochemistry research. For
instance, in January 2017, University of Chicago installed a new cyclotron research facility
at its campus to facilitate research in cancer therapies. However, medical cyclotrons
requires huge capital investment that limits its use to a few end users. Moreover,
commercial availability of isotopes with long half-life could deter growth for the medical
cyclotron market.
Request sample copy of this Report,
https://www.coherentmarketinsights.com/insight/request-sample/2039